Table 5.

Significant correlations between and among serum concentrations of carnitine and BCAA-derived acylcarnitines by group

Group	Variable 1	Variable 2	Spearman r	P (two tailed)
Control subjects	Carnitine	C5	0.532	0.030
T2D patients with hyperglycemia	Carnitine	C5	0.675	0.001
		C3	0.826	<0.001
	C5	C3	0.804	<0.001
KPD patients with DKA	Carnitine	C5	0.551	<0.001
		C3	0.537	<0.001
T1D patients with DKA	Carnitine	C5	0.465	0.034
		C3	0.509	0.018